Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy
<strong>Objectives</strong> This post hoc analysis assessed speed, magnitude and maintenance of pain improvement in patients with early rheumatoid arthritis (RA) receiving baricitinib, baricitinib and methotrexate (MTX), or MTX over 1 year. Cumulative pain and quality of life benefits we...
Autors principals: | Taylor, P, Alten, R, Álvaro-Gracia, JM, Kaneko, Y, Walls, C, Quebe, A, Jia, B, Bello, N, Terres, JR, Fleischmann, RM |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
BMJ Publishing Group
2022
|
Ítems similars
-
Achieving pain control in rheumatoid arthritis with baricitinib or ddalimumab plus methotrexate: Results from the RA-BEAM Trial
per: Taylor, P, et al.
Publicat: (2019) -
Treating rheumatoid arthritis with leflunomide monotherapy versus combination therapy with methotrexate
per: Daniel Ampessan Guadagnin, et al.
Publicat: (2021-01-01) -
Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis
per: E E Gubar', et al.
Publicat: (2008-05-01) -
Safety and efficacy of Methotrexate Monotherapy Vs Methotrexate Plus Leflunomide Combination Therapy in Early Active Rheumatoid Arthritis Patients
per: Mariane S. Boshra, et al.
Publicat: (2016-03-01) -
COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM
per: Purcaru, O, et al.
Publicat: (2010)